Organization name
DEPT OF PHARMACY


Results 1-20 of 1585 (Search time: 0.025 seconds).

Issue DateTitleAuthor(s)
12017ZnO nano-rod devices for intradermal delivery and immunizationNayak, T.R ; Wang, H ; Pant, A ; Zheng, M ; Junginger, H ; Goh, W.J ; Lee, C.K ; Zou, S; Alonso, S ; Czarny, B; Storm, G; Sow, C.H ; Lee, C ; Pastorin, G 
2May-2011Zebrafish for drug toxicity screening: Bridging the in vitro cell-based models and in vivo mammalian modelsSukardi, H.; Chng, H.T.; Chan, E.C.Y. ; Gong, Z. ; Lam, S.H. 
32013Willingness-to-pay and preferences for warfarin pharmacogenetic testing in Chinese warfarin patients and the Chinese general publicChan, S.L.; Wen Low, J.J.; Lim, Y.W.; Finkelstein, E.; Farooqui, M.A.; Chia, K.S. ; Wee, H.L. 
4Mar-2004What Is Next for Pharmacoeconomics and Outcomes Research in Asia?Doherty, J.; Kamae, I.; Lee, K.K.C.; Li, H.; Li, S.-C. ; Liu, G.G.; Tarn, Y.-H.; Yang, B.-M.
52006What health domains and items are important to patients with knee osteoarthritis? A focus group study in a multiethnic urban Asian populationXie, F. ; Li, S.-C. ; Fong, K.-Y. ; Thumboo, J. ; Lo, N.N.; Yeo, S.-J.; Yang, K.-Y.
628-Nov-2012What Does It Take to Synergistically Combine Sub-Potent Natural Products into Drug-Level Potent Combinations?Qin, C.; Tan, K.L.; Zhang, C.L.; Tan, C.Y.; Chen, Y.Z. ; Jiang, Y.Y.
7Jul-2009What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targets.Zhu, F. ; Han, L. ; Zheng, C. ; Xie, B.; Tammi, M.T. ; Yang, S.; Wei, Y.; Chen, Y. 
82009What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targets.Zhu, F. ; Han, L. ; Zheng, C.; Xie, B.; Tammi, M.T. ; Yang, S.; Wei, Y.; Chen, Y. 
9Jul-2009What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targetsZhu, F. ; Han, L. ; Zheng, C. ; Xie, B.; Tammi, M.T. ; Yang, S.; Wei, Y.; Chen, Y. 
102009What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targetsZhu, F. ; Han, L. ; Zheng, C.; Xie, B.; Chen, Y. ; Tammi, M.T. ; Yang, S.; Wei, Y.
112004Wet Spheronization by Rotary Processing - A Multistage Single-Pot Process for Producing SpheroidsGu, L.; Liew, C.V. ; Heng, P.W.S. 
122008Vision Impairment, Ocular Conditions, and Vision-specific Function: The Singapore Malay Eye StudyLamoureux, E.L.; Chong, E.W.; Wang, J.J.; Wong, T.Y. ; Thumboo, J. ; Wee, H.L. ; Saw, S.-M. ; Aung, T. 
1317-Mar-2010Virtual screening prediction of new potential organocatalysts for direct aldol reactionsLiu, X.H.; Song, H.Y.; Ma, X.H. ; Lear, M.J.; Chen, Y.Z. 
144-Oct-2010Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machinesMa, X.H. ; Wang, R.; Tan, C.Y.; Jiang, Y.Y.; Lu, T.; Rao, H.B.; Li, X.Y.; Go, M.L. ; Low, B.C. ; Chen, Y.Z. 
1528-Sep-2009Virtual screening of bl inhibitors from large compound libraries by support vector machinesLiu, X.H.; Ma, X.H. ; Tan, C.Y.; Jiang, Y.Y.; Go, M.L. ; Low, B.C. ; Chen, Y.Z. 
16Nov-2012Virtual screening methods as tools for drug lead discovery from large chemical librariesMa, X.H. ; Zhu, F.; Liu, X.; Shi, Z.; Zhang, J.X.; Yang, S.Y.; Wei, Y.Q.; Chen, Y.Z. 
1719-Sep-2016Viability of Transarctic Shipping Routes: A Literature Review from the Navigational and Commercial PerspectivesQiang Meng ; Yiru Zhang ; Min Xu
182010Versatile coordination chemistry of indazole-derived carbenesJothibasu, R. ; Huynh, H.V. 
191990VASCULAR MUSCARINIC RECEPTORS IN THE AORTA OF THE RABBIT AND HYPERTENSIVE RATSMANJEET SINGH
20Jan-2014Vascular endothelial growth factor inhibitors and cognitive impairment: Evidence and controversiesNg, T.; Cheung, Y.T.; Ng, Q.S.; Ho, H.K. ; Chan, A.